a developer of transformative glucose monitoring products
Industry MedicalSpecialties
A.I.dvisor tells us that SENS and ARAY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SENS and ARAY's prices will move in lockstep.
Ticker / NAME | Correlation To SENS | 1D Price Change % | ||
---|---|---|---|---|
SENS | 100% | -5.21% | ||
ARAY - SENS | 31% Poorly correlated | -3.87% | ||
TNDM - SENS | 29% Poorly correlated | -3.64% | ||
OSUR - SENS | 28% Poorly correlated | -1.48% | ||
NNOX - SENS | 28% Poorly correlated | -3.13% | ||
BNGO - SENS | 28% Poorly correlated | -7.58% | ||
More |
Ticker / NAME | Correlation To SENS | 1D Price Change % |
---|---|---|
SENS | 100% | -5.21% |
components theme (43 stocks) | 27% Poorly correlated | -0.86% |
wearables theme (15 stocks) | 26% Poorly correlated | +0.31% |
transformative theme (4 stocks) | 26% Poorly correlated | -7.14% |
electronic theme (153 stocks) | 25% Poorly correlated | -0.90% |
Medical Specialties theme (427 stocks) | 21% Poorly correlated | -1.35% |
More |